Discontinued — last reported Q3 '23
Intuit Interest Paid remained flat by 0.0% to $71.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 42.0%, from $50.00M to $71.00M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 75.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $30.00M | $67.00M | $272.00M | $200.00M | $284.00M |
| YoY Change | — | +123.3% | +306.0% | -26.5% | +42.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.